The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure
about
Ethical dilemmas surrounding the use of ventricular assist devices in supporting patients with end-stage organ dysfunctionWhy pulsatility still matters: a review of current knowledgeHepato-cardiac disordersEndocarditis in left ventricular assist deviceSecond INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.Acoustic analysis of a mechanical circulatory supportRisk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support.Towards non-thrombogenic performance of blood recirculating devicesThirty-five years of mechanical circulatory support at the Texas Heart Institute: an updated overview.Cardiomyopathy. Diagnosis and management of dilated cardiomyopathyCardiac Health Risk Stratification System (CHRiSS): a Bayesian-based decision support system for left ventricular assist device (LVAD) therapy.Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist deviceMechanical circulatory support after heart transplantation.A synopsis of research in cardiac apoptosis and its application to congestive heart failureClinical, molecular, and genomic changes in response to a left ventricular assist deviceMultidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.Ventricular assist devices: is destination therapy a viable alternative in the non-transplant candidate?Limited Utility of Tricuspid Valve Repair at the Time of Left Ventricular Assist Device Implantation.Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device.Comparing administration of questionnaires via the internet to pen-and-paper in patients with heart failure: randomized controlled trialAdvanced Strategies for End-Stage Heart Failure: Combining Regenerative Approaches with LVAD, a New Horizon?Left ventricular assist devices as permanent heart failure therapy: the price of progress.Pediatric mechanical circulatory support.An overview of approved and investigational left ventricular assist devices.Insanity of left ventricular assist therapy: doing the same thing and expecting different results.Mechanical Circulatory Support for Advanced Heart Failure: Are We about to Witness a New "Gold Standard"?Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.
P2860
Q26824420-AE188ABE-3453-4D91-999B-98038B0CEBA2Q26864718-D9E5A0C3-B085-405A-B02D-80210F350252Q26997114-798D8DAD-4D57-40C2-B885-A410C50EB3CDQ28067759-7BA7609B-D515-4921-AD9C-8C329563ECA0Q30425010-F504416C-1F0B-4AC7-AB1E-32ACC291C03FQ30426101-B97D7D53-D6F9-459A-8FC8-060F047CB4E3Q33390013-82653044-18D4-414C-AFCB-AA7085A09F71Q33822427-3D6A6668-C4B3-4B42-9A90-8286FD9B74E8Q33873876-86D255CA-9789-4904-BF1C-1526ADCBA829Q33947702-4907FB4E-6238-4F89-90BF-E588021F725EQ34513055-FDCFF950-192F-4AD9-88E7-495F99BB2F58Q35597572-96CECCDB-B789-4971-8081-4F13655135B6Q35619903-6C1353BE-AC3B-4288-BA39-5A8499886EFCQ36015485-49BBFAE5-08EA-4D02-A8D7-0D9A832212DCQ36054446-48B43BE4-AA7C-451C-B4A0-51C604025FCCQ36334445-4B744CE0-3234-4E62-86D2-98502D64780FQ36597965-D07D8A2C-37D0-48FF-81C9-742017CE45FEQ36927453-DD5BCF20-E361-4DDF-BE8E-AA9040406D8BQ36932155-6DE162EC-B681-4C01-ABD3-357DB4BB25EFQ37389197-3E6BEE94-BA4B-4CF9-8853-69F28B330FADQ38437316-32AE30F6-8FCC-4BB6-908E-5738A13A9E75Q40557615-BB2B34FA-9230-443C-BBF0-FE58806D2F07Q42203387-C3C76DE0-A788-47F5-85B6-63127A704DB8Q42956176-3FB4E55B-2E00-447F-BFCF-5A4ADB38C646Q43043986-8DD06703-D5BD-433D-86B5-2AA8C360E1ADQ47556856-CAAE6EA9-85B1-44DD-A462-8E42DE7A4A65Q47860273-CDA6B77C-5947-4DB7-A59D-7F04AD5A5FCB
P2860
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The REMATCH trial: rationale, ...... nt of Congestive Heart Failure
@ast
The REMATCH trial: rationale, ...... nt of Congestive Heart Failure
@en
The REMATCH trial: rationale, ...... nt of Congestive Heart Failure
@nl
type
label
The REMATCH trial: rationale, ...... nt of Congestive Heart Failure
@ast
The REMATCH trial: rationale, ...... nt of Congestive Heart Failure
@en
The REMATCH trial: rationale, ...... nt of Congestive Heart Failure
@nl
prefLabel
The REMATCH trial: rationale, ...... nt of Congestive Heart Failure
@ast
The REMATCH trial: rationale, ...... nt of Congestive Heart Failure
@en
The REMATCH trial: rationale, ...... nt of Congestive Heart Failure
@nl
P2093
P1476
The REMATCH trial: rationale, ...... nt of Congestive Heart Failure
@en
P2093
A C Gelijns
A D Weinberg
A J Moskowitz
A R Tierney
D D Ascheim
D F Heitjan
D J Goldstein
D L Williams
J A Sollano
P304
P407
P577
1999-03-01T00:00:00Z